EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Pfs48/45 nanobodies block Plasmodium falciparum transmission

Frankie M T Lyons, Jill Chmielewski, Mikha Gabriela, Li-Jin Chan, Joshua Tong, Amy Adair, Kathleen Zeglinski, Quentin Gouil, Melanie H Dietrich, Wai-Hong Tham iD

PLOS Pathogens · 27.01.2026 · 22 (1) · e1013884

DOI: 10.1371/journal.ppat.1013884 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Pathogens, online erschienen am 27.01.2026. Verfasst von Frankie M T Lyons und 9 weiteren Autor:innen. Beteiligte Einrichtung: The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia. Hauptthemen laut MEDLINE: Plasmodium falciparum, Protozoan Proteins, Malaria, Falciparum, Single-Domain Antibodies. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Health and Medical Research Council, Victorian State Government Operational Infrastructure Support, Australian Government NHMRC IRIISS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Malaria parasite fertilisation occurs within the Anopheles mosquito midgut. Interventions that inhibit parasite fertilisation prevent ongoing transmission and are important for malaria elimination efforts. Pfs48/45 and Pfs230 are two leading transmission-blocking vaccine candidates. Both proteins form a complex on the surface of sexual stage parasites and are essential for male fertility. Here we have identified nanobodies against Pfs48/45 that recognise gametocytes and have strong transmission-reducing activity. The crystal structure of our most potent nanobody in complex with Pfs48/45 reveals it binds a distinct epitope to TB31F, a leading transmission-blocking monoclonal antibody but to similar epitopes as RUPA-44 and RUPA-117. These results demonstrate the potential of nanobodies as a versatile antibody format that can reduce malaria transmission.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Plasmodium falciparumProtozoan ProteinsMalaria, FalciparumSingle-Domain AntibodiesAntibodies, ProtozoanAnimalsHumansCrystallography, X-RayMalaria VaccinesAntibodies, MonoclonalMembrane Glycoproteins

Substanzen

Protozoan ProteinsSingle-Domain AntibodiesAntibodies, Protozoanpfs48-45 protein, Plasmodium falciparumMalaria VaccinesAntibodies, MonoclonalMembrane Glycoproteins

Autor:innen und Institutionen

  • The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia.
  • Department of Medical Biology, The University of Melbourne, Parkville, Victoria, Australia.
  • Olivia Newton-John Cancer Research Institute, Heidelberg, Victoria, Australia.
  • School of Cancer Medicine, La Trobe University, Bundoora, Victoria, Australia.
  • Research School of Biology, The Australian National University, Canberra, ACT, Australia.

ORCID-Profile: Wai-Hong Tham

Förderung

  • National Health and Medical Research Council
  • Victorian State Government Operational Infrastructure Support
  • Australian Government NHMRC IRIISS

Zitieren

APA

Lyons, F. M. T., Chmielewski, J., Gabriela, M., Chan, L. J., Tong, J., Adair, A., Zeglinski, K., Gouil, Q., Dietrich, M. H., & Tham, W. H. (2026). Pfs48/45 nanobodies block Plasmodium falciparum transmission. PLOS Pathogens, 22(1), e1013884. https://doi.org/10.1371/journal.ppat.1013884

Vancouver

Lyons FMT, Chmielewski J, Gabriela M, Chan LJ, Tong J, Adair A, et al. Pfs48/45 nanobodies block Plasmodium falciparum transmission. PLOS Pathogens. 2026;22(1):e1013884. doi:10.1371/journal.ppat.1013884

BibTeX
@article{Lyons2026,
  author = {Lyons, Frankie M T and Chmielewski, Jill and Gabriela, Mikha and Chan, Li-Jin and Tong, Joshua and Adair, Amy and Zeglinski, Kathleen and Gouil, Quentin and Dietrich, Melanie H and Tham, Wai-Hong},
  title = {Pfs48/45 nanobodies block Plasmodium falciparum transmission},
  journal = {PLOS Pathogens},
  year = {2026},
  volume = {22},
  number = {1},
  pages = {e1013884},
  doi = {10.1371/journal.ppat.1013884}
}
Kostenlos starten →